Bradmer Pharmaceuticals Inc.: Director Resignation

TORONTO, ONTARIO--(Marketwired - July 31, 2013) - Bradmer Pharmaceuticals Inc. (the "Corporation") (TSX VENTURE:BMR.H) announced today that Perry N. Dellelce has resigned as a director of the Corporation. He will continue to act as a consultant to the Corporation. The Corporation thanks Mr. Dellelce for his commitment and significant past contribution to the Corporation.

NEITHER THE TSX VENTURE EXCHANGE NOR ITS REGULATION PROVIDER (AS THAT TERM IS DEFINED IN THE POLICIES OF THE TSX VENTURE EXCHANGE) ACCEPTS RESPONSIBILITY FOR THE ADEQUACY OR ACCURACY OF THIS RELEASE.